Correlation Between Fate Therapeutics and Lexaria Bioscience
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Lexaria Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Lexaria Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Lexaria Bioscience Corp, you can compare the effects of market volatilities on Fate Therapeutics and Lexaria Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Lexaria Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Lexaria Bioscience.
Diversification Opportunities for Fate Therapeutics and Lexaria Bioscience
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Fate and Lexaria is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Lexaria Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexaria Bioscience Corp and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Lexaria Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexaria Bioscience Corp has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Lexaria Bioscience go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Lexaria Bioscience
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Lexaria Bioscience. In addition to that, Fate Therapeutics is 1.52 times more volatile than Lexaria Bioscience Corp. It trades about -0.14 of its total potential returns per unit of risk. Lexaria Bioscience Corp is currently generating about -0.08 per unit of volatility. If you would invest 297.00 in Lexaria Bioscience Corp on September 26, 2024 and sell it today you would lose (74.00) from holding Lexaria Bioscience Corp or give up 24.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Lexaria Bioscience Corp
Performance |
Timeline |
Fate Therapeutics |
Lexaria Bioscience Corp |
Fate Therapeutics and Lexaria Bioscience Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Lexaria Bioscience
The main advantage of trading using opposite Fate Therapeutics and Lexaria Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Lexaria Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexaria Bioscience will offset losses from the drop in Lexaria Bioscience's long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Lexaria Bioscience vs. Fate Therapeutics | Lexaria Bioscience vs. Caribou Biosciences | Lexaria Bioscience vs. Karyopharm Therapeutics | Lexaria Bioscience vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |